Brief: Oncolytics Biotech Presents Clinical Data Supporting A Predictive Biomarker Of Pelareorep Response In Breast Cancer At Esmo Breast Cancer Virtual Meeting
26/05/2020 12:21
May 26 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® PRESENTS CLINICAL DATA SUPPORTING A
PREDICTIVE BIOMARKER OF PELAREOREP RESPONSE IN BREAST CANCER AT
THE ESMO BREAST CANCER VIRTUAL MEETING
Source text for Eikon: ID:nCNWbftD1a
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer